- Home
- CRIS vs SCNX Comparison
CRIS vs SCNX Comparison
Compare CRIS & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- SCNX
- Stock Information
- Founded
- CRIS 2000
- SCNX 2010
- Country
- CRIS United States
- SCNX United States
- Employees
- CRIS N/A
- SCNX N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- SCNX Other Pharmaceuticals
- Sector
- CRIS Health Care
- SCNX Health Care
- Exchange
- CRIS Nasdaq
- SCNX Nasdaq
- Market Cap
- CRIS 22.9M
- SCNX 21.2M
- IPO Year
- CRIS 2000
- SCNX 2020
- Fundamental
- Price
- CRIS $1.72
- SCNX $0.89
- Analyst Decision
- CRIS Strong Buy
- SCNX
- Analyst Count
- CRIS 2
- SCNX 0
- Target Price
- CRIS $16.50
- SCNX N/A
- AVG Volume (30 Days)
- CRIS 75.0K
- SCNX 486.2K
- Earning Date
- CRIS 11-13-2025
- SCNX 11-05-2025
- Dividend Yield
- CRIS N/A
- SCNX N/A
- EPS Growth
- CRIS N/A
- SCNX N/A
- EPS
- CRIS N/A
- SCNX N/A
- Revenue
- CRIS $11,405,000.00
- SCNX $128,202.00
- Revenue This Year
- CRIS $2.72
- SCNX N/A
- Revenue Next Year
- CRIS $8.27
- SCNX N/A
- P/E Ratio
- CRIS N/A
- SCNX N/A
- Revenue Growth
- CRIS 12.24
- SCNX N/A
- 52 Week Low
- CRIS $1.02
- SCNX $0.69
- 52 Week High
- CRIS $6.44
- SCNX $9.55
- Technical
- Relative Strength Index (RSI)
- CRIS 49.68
- SCNX 33.92
- Support Level
- CRIS $1.63
- SCNX $0.86
- Resistance Level
- CRIS $1.95
- SCNX $1.16
- Average True Range (ATR)
- CRIS 0.15
- SCNX 0.08
- MACD
- CRIS 0.00
- SCNX 0.02
- Stochastic Oscillator
- CRIS 28.13
- SCNX 19.10
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.